Talaris Therapeutics to Participate in Two Upcoming Investor Conferences

Rhea-AI Summary

Talaris Therapeutics, Inc. (Nasdaq: TALS) announced participation in two key investor conferences. The first is the Morgan Stanley 20th Annual Global Healthcare Conference on September 12, 2022, at 1:40 p.m. ET in New York. The second is the H.C. Wainwright 24th Annual Global Investment Conference on September 14, 2022, at 9:00 a.m. ET, also in New York. A live webcast of the presentations will be available on Talaris' investor website, with replays accessible post-event.

BOSTON and LOUISVILLE Ky., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc. (Nasdaq: TALS), a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation and severe immune and blood disorders, today announced that members of its senior management team will participate in the following investor conferences:

Morgan Stanley 20th Annual Global Healthcare Conference
Fireside chat date: Monday, September 12, 2022
Fireside chat time: 1:40 p.m. ET
Location: Sheraton Hotel, New York, NY

H.C. Wainwright 24th Annual Global Investment Conference
Presentation date: Wednesday, September 14, 2022
Presentation time: 9:00 a.m. ET
Location: Lotte New York Palace Hotel, New York, NY

A live webcast of the presentations will be available on the investors section of the Talaris website at www.talaristx.com. After the live webcast, a replay of the events can be found on the Talaris website.

About Talaris Therapeutics
Talaris Therapeutics, Inc. is a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation and severe immune and blood disorders. Talaris maintains corporate offices in Boston, MA, its cell processing facility in Louisville, KY, and additional research operations in Houston, TX.

Media Contact
Lisa Raffensperger
Ten Bridge Communications
lisa@tenbridgecommunications.com
(617) 903-8783

Investor Contact
Chris Brinzey
ICR Westwicke
chris.brinzey@westwicke.com
(339) 970-2843

FAQ

When will Talaris Therapeutics participate in the Morgan Stanley conference?

Talaris Therapeutics will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on September 12, 2022, at 1:40 p.m. ET.

What is the date and time for Talaris Therapeutics at the H.C. Wainwright conference?

Talaris Therapeutics will present at the H.C. Wainwright 24th Annual Global Investment Conference on September 14, 2022, at 9:00 a.m. ET.

Where can I watch Talaris Therapeutics' investor presentations?

Talaris Therapeutics' presentations can be viewed live on their investor website, with replays available after the events.

What is the focus of Talaris Therapeutics?

Talaris Therapeutics focuses on developing therapies for solid organ transplantation and severe immune and blood disorders.

What are the locations of Talaris Therapeutics' operations?

Talaris Therapeutics has corporate offices in Boston, MA, a cell processing facility in Louisville, KY, and research operations in Houston, TX.